Spectrum Pharmaceuticals Company Profile (NASDAQ:SPPI)

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals logoSpectrum Pharmaceuticals, Inc. is a biotechnology company. The Company operates through developing and commercializing oncology and hematology drug products segment. It has approximately six approved oncology/hematology products that target different types of non-Hodgkin's lymphoma (NHL), metastatic colorectal cancer, acute lymphoblastic leukemia (ALL) and multiple myeloma (MM). It also has two drugs in late-stage development: SPI-2012, which is being developed for chemotherapy-induced neutropenia in patients with breast cancer, and EOQUIN, which is being developed for immediate intravesical instillation post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer. It has a product portfolio consisting of both commercial-stage and development-stage products that address various cancer types. Its commercialized products include FUSILEV, FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ and EVOMELA. Its other products include SPI-2012, POZIOTINIB and EOQUIN.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: SPPI
  • CUSIP: 84763A10
Key Metrics:
  • Previous Close: $4.58
  • 50 Day Moving Average: $5.36
  • 200 Day Moving Average: $6.47
  • 52-Week Range: $4.14 - $7.74
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.26
  • P/E Growth: 0.00
  • Market Cap: $314.07M
  • Outstanding Shares: 68,575,000
  • Beta: 1.47
Profitability:
  • Net Margins: -36.04%
  • Return on Equity: -11.24%
  • Return on Assets: -5.76%
Debt:
  • Debt-to-Equity Ratio: 0.43%
  • Current Ratio: 3.54%
  • Quick Ratio: 3.43%
Additional Links:
Companies Related to Spectrum Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Spectrum Pharmaceuticals (NASDAQ:SPPI) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $9.60 (109.61% upside)

Analysts' Ratings History for Spectrum Pharmaceuticals (NASDAQ:SPPI)
Show:
DateFirmActionRatingPrice TargetDetails
9/16/2016HC WainwrightReiterated RatingBuy$10.00View Rating Details
9/15/2016FBR & CoReiterated RatingBuyView Rating Details
9/15/2016RBC Capital MarketsSet Price TargetBuy$11.00 -> $10.00View Rating Details
5/9/2016Jefferies GroupReiterated RatingHold$5.00 -> $6.00View Rating Details
11/5/2015Royal Bank Of CanadaLower Price TargetOutperform$13.00 -> $12.00View Rating Details
8/18/2015Roth CapitalReiterated RatingNeutral$6.00View Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Spectrum Pharmaceuticals (NASDAQ:SPPI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2016        
8/9/2016Q216($0.29)($0.05)$30.88 million$33.90 millionViewN/AView Earnings Details
5/5/2016Q1($0.32)($0.14)$28.83 million$43.90 millionViewN/AView Earnings Details
3/9/2016Q415($0.18)($0.06)$33.87 million$50.30 millionViewN/AView Earnings Details
11/4/2015Q315($0.25)($0.28)$31.87 million$28.46 millionViewN/AView Earnings Details
8/6/2015Q215($0.22)($0.01)$34.48 million$44.98 millionViewN/AView Earnings Details
5/7/2015Q115($0.06)($0.07)$48.00 million$38.60 millionViewN/AView Earnings Details
3/13/2015Q414($0.16)$0.09$48.50 million$51.70 millionViewN/AView Earnings Details
11/6/2014Q314($0.17)$0.08$45.00 million$47.99 millionViewN/AView Earnings Details
8/7/2014Q214($0.09)$0.09$41.50 million$46.90 millionViewListenView Earnings Details
5/8/2014Q114($0.22)$0.01$39.49 million$40.10 millionViewListenView Earnings Details
3/6/2014Q313($0.11)$0.05$41.96 million$41.50 millionViewListenView Earnings Details
11/12/2013Q3($0.07)($0.13)$38.70 million$42.44 millionViewListenView Earnings Details
8/7/2013Q2 2013($0.12)($0.08)$33.41 million$33.23 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.32)($0.06)ViewN/AView Earnings Details
11/7/2012Q312$0.29$0.42$68.56 million$69.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Spectrum Pharmaceuticals (NASDAQ:SPPI)
Current Year EPS Consensus Estimate: $-1.07 EPS
Next Year EPS Consensus Estimate: $-0.87 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164($0.36)($0.21)($0.28)
Q2 20164($0.39)($0.25)($0.32)
Q3 20162($0.34)($0.29)($0.32)
Q4 20162($0.32)($0.29)($0.31)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Spectrum Pharmaceuticals (NASDAQ:SPPI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/11/2012special$0.1512/18/201212/20/201212/28/2012
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Spectrum Pharmaceuticals (NASDAQ:SPPI)
Insider Ownership Percentage: 14.50%
Institutional Ownership Percentage: 68.67%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/5/2013Anthony E Maida IIIDirectorSell5,000$12.25$61,250.00View SEC Filing  
11/12/2012Joseph Kenneth KellerCOOBuy10,000$10.95$109,500.00View SEC Filing  
11/1/2012Anthony E Maida IIIDirectorSell5,000$11.09$55,450.00View SEC Filing  
9/4/2012Anthony E Maida IIIDirectorSell5,000$12.01$60,050.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Spectrum Pharmaceuticals (NASDAQ:SPPI)
DateHeadline
4-traders.com logoSPECTRUM PHARMACEUTICALS, INC. : IMPORTANT SPECTRUM PHARMACEUTICALS, INC. Wolf.. (NASDAQ:SPPI)
www.4-traders.com - September 29 at 12:31 PM
finance.yahoo.com logoIMPORTANT SPECTRUM PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of shareholders of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)
finance.yahoo.com - September 29 at 12:31 PM
insidermonkey.com logoInside The FDA: Spectrum Pharmaceuticals, Inc. (SPPI) and its Bladder Cancer Treatment, Apaziquone - Insider Monkey (blog) (NASDAQ:SPPI)
www.insidermonkey.com - September 28 at 12:39 PM
News IconInside The FDA: Spectrum Pharmaceuticals, Inc. (SPPI) and its Bladder Cancer Treatment, Apaziquone (NASDAQ:SPPI)
feedproxy.google.com - September 28 at 7:58 AM
businesswire.com logoRobbins Arroyo LLP: Spectrum Pharmaceuticals, Inc. (SPPI) Misled ... - Business Wire (press release) (NASDAQ:SPPI)
www.businesswire.com - September 27 at 7:20 PM
finance.yahoo.com logoRobbins Arroyo LLP: Spectrum Pharmaceuticals, Inc. (SPPI) Misled Shareholders According to a Recently Filed Class Action (NASDAQ:SPPI)
finance.yahoo.com - September 27 at 7:20 PM
4-traders.com logoLawsuit for Certain Investors in Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Filed (NASDAQ:SPPI)
www.4-traders.com - September 27 at 12:02 PM
marketexclusive.com logoInside The FDA: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI ... - Market Exclusive (NASDAQ:SPPI)
marketexclusive.com - September 25 at 12:23 PM
4-traders.com logoInside The FDA: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) and its Bladder Cancer Treatment, Apaziquone (NASDAQ:SPPI)
www.4-traders.com - September 24 at 11:46 AM
businesswire.com logoINVESTOR ALERT: Investigation of Spectrum Pharmaceuticals, Inc. Announced by Law Offices of Howard G. Smith - Business Wire (press release) (NASDAQ:SPPI)
www.businesswire.com - September 23 at 6:50 PM
4-traders.com logoInvestigation of Spectrum Pharmaceuticals, Inc. Announced by Law Offices of Howard G. Smith (NASDAQ:SPPI)
www.4-traders.com - September 23 at 11:58 AM
finance.yahoo.com logoSPECTRUM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Spectrum Pharmaceuticals Inc. Investors to Class Action and Lead Plaintiff Deadline (NASDAQ:SPPI)
finance.yahoo.com - September 23 at 11:58 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. - SPPI (NASDAQ:SPPI)
finance.yahoo.com - September 23 at 11:58 AM
finance.yahoo.com logoINVESTOR ALERT: Investigation of Spectrum Pharmaceuticals, Inc. Announced by Law Offices of Howard G. Smith (NASDAQ:SPPI)
finance.yahoo.com - September 23 at 11:58 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Spectrum Pharmaceuticals Inc. (SPPI) and Lead Plaintiff Deadline: November 21, 2016 (NASDAQ:SPPI)
finance.yahoo.com - September 22 at 7:03 PM
businesswire.com logoGlancy Prongay & Murray LLP Commences Investigation on Behalf of Spectrum Pharmaceuticals, Inc. Investors - Business Wire (press release) (NASDAQ:SPPI)
www.businesswire.com - September 22 at 11:38 AM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Files Securities Class Action Against Spectrum Pharmaceuticals, Inc. - SPPI (NASDAQ:SPPI)
finance.yahoo.com - September 21 at 6:58 PM
finance.yahoo.com logoGlancy Prongay & Murray LLP Commences Investigation on Behalf of Spectrum Pharmaceuticals, Inc. Investors (NASDAQ:SPPI)
finance.yahoo.com - September 21 at 6:58 PM
finance.yahoo.com logoSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Spectrum Pharmaceuticals, Inc. To Contact The Firm (NASDAQ:SPPI)
finance.yahoo.com - September 21 at 6:58 PM
finance.yahoo.com logoSPECTRUM PHARMACEUTICALS NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses … (NASDAQ:SPPI)
finance.yahoo.com - September 21 at 11:33 AM
4-traders.com logoSPECTRUM PHARMACEUTICALS Hagens Berman is Investigating Possible Securities Law Violations by Spectrum Pharmaceuticals Inc. and Officers (NASDAQ:SPPI)
www.4-traders.com - September 21 at 11:33 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)
finance.yahoo.com - September 21 at 11:33 AM
finance.yahoo.com logoHynes Keller & Hernandez, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc. (SPPI) (NASDAQ:SPPI)
finance.yahoo.com - September 21 at 11:33 AM
finance.yahoo.com logoSPECTRUM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman is Investigating Possible Securities Law Violations by Spectrum Pharmaceuticals Inc. and Officers (NASDAQ:SPPI)
finance.yahoo.com - September 21 at 11:33 AM
News IconSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI): Disappointing Cancer Treatment Results Sparks Selloff - Scibility Media (NASDAQ:SPPI)
scibilitymedia.com - September 20 at 11:14 AM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm (NASDAQ:SPPI)
finance.yahoo.com - September 20 at 11:14 AM
finance.yahoo.com logoSPECTRUM PHARMACEUTICALS NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Spectrum Pharmaceuticals, Inc. To Contact The Firm (NASDAQ:SPPI)
finance.yahoo.com - September 20 at 11:14 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)
finance.yahoo.com - September 20 at 11:14 AM
News IconStock Revamps on Eco Changes: Novavax, Inc. (NASDAQ:NVAX), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Street Wise Report (press release) (blog) (NASDAQ:SPPI)
streetwisereport.com - September 19 at 7:22 PM
seekingalpha.com logoDisappointment Is Coming For Spectrum Pharmaceuticals - Seeking Alpha (NASDAQ:SPPI)
seekingalpha.com - September 19 at 7:22 PM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)
finance.yahoo.com - September 19 at 7:22 PM
News IconIntraday Active Biotech Stocks News: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Keryx Biopharmaceuticals Inc ... - The Voice Registrar (NASDAQ:SPPI)
voiceregistrar.com - September 19 at 11:57 AM
prnewswire.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals ... - PR Newswire (press release) (NASDAQ:SPPI)
www.prnewswire.com - September 19 at 11:57 AM
News IconSpectrum Pharmaceuticals Inc. (NASDAQ: SPPI) Buy Rating Reiterated at HC Wainwright - BNB Daily (blog) (NASDAQ:SPPI)
www.baseball-news-blog.com - September 19 at 11:57 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals Inc. (SPPI) (NASDAQ:SPPI)
finance.yahoo.com - September 19 at 11:57 AM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm (NASDAQ:SPPI)
finance.yahoo.com - September 19 at 11:57 AM
4-traders.com logoGoldberg Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)
www.4-traders.com - September 17 at 6:51 PM
News IconBiotech Stocks To Put On Your Watch List: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), ACADIA Pharmaceuticals ... - The Voice Registrar (NASDAQ:SPPI)
voiceregistrar.com - September 17 at 11:49 AM
smarteranalyst.com logoHC Wainwright Remains Positive on Spectrum Pharmaceuticals, Inc. (SPPI) Despite FDA AdCom Setback - Smarter Analyst (NASDAQ:SPPI)
www.smarteranalyst.com - September 17 at 11:49 AM
finance.yahoo.com logoINVESTOR ALERT: Goldberg Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)
finance.yahoo.com - September 17 at 11:49 AM
thestreet.com logoSpectrum Pharma, FDA and the Buried Truth About a Bladder Cancer Drug Meeting (NASDAQ:SPPI)
www.thestreet.com - September 16 at 7:07 PM
finance.yahoo.com logoBlock & Leviton LLP Investigates Spectrum Pharmaceuticals After Revelation That Company Concealed Discouraging Advice From FDA (NASDAQ:SPPI)
finance.yahoo.com - September 16 at 7:07 PM
finance.yahoo.com logoSpectrum (SPPI) Down, Qapzola Fails to Impress FDA Panel (NASDAQ:SPPI)
finance.yahoo.com - September 15 at 7:31 PM
rttnews.com logoData Boosts AERI, FDA Panel Snubs SPPI, D-Day For ACRX Today, VTAE Abuzz (NASDAQ:SPPI)
www.rttnews.com - September 15 at 11:05 AM
News IconFDA Advisory Committee Votes that Qapzola (apaziquone) Has Not Shown Substantial Evidence of a Treatment Effect Over Placebo (NASDAQ:SPPI)
www.pressreleasepoint.com - September 15 at 11:05 AM
News IconSpectrum bladder cancer drug not effective: US FDA panel (NASDAQ:SPPI)
www.channelnewsasia.com - September 14 at 7:35 PM
4-traders.com logoSPECTRUM PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K) (NASDAQ:SPPI)
www.4-traders.com - September 14 at 7:35 PM
schaeffersresearch.com logoSpectrum Pharmaceuticals, Inc. (SPPI) Sinks On Qapzola Finding (NASDAQ:SPPI)
www.schaeffersresearch.com - September 14 at 7:35 PM
finance.yahoo.com logo1:07 pm Spectrum Pharma confirms that an FDA advisory committee voted that Qapzola has not shown substantial evidence of a treatment effect over placebo (NASDAQ:SPPI)
finance.yahoo.com - September 14 at 7:35 PM
marketwatch.com logoSpectrum Pharmaceuticals' stock drops after cancer treatment voted down by FDA committee (NASDAQ:SPPI)
www.marketwatch.com - September 14 at 7:35 PM

Social

Spectrum Pharmaceuticals (NASDAQ:SPPI) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff